Skip to main content
OpenTrials

Clinical trial condition

Advanced Adult Hepatocellular Carcinoma

Explore clinical trials studying Advanced Adult Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

22 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Advanced Adult Hepatocellular Carcinoma trial results

Completed

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

NCT01015833

Conditions
Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +18 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Alaska Regional Hospital Anchorage, Alaska, United States
View all 673 locations
View Trial Details
Completed

A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma

NCT02234986

Conditions
Advanced Adult Hepatocellular Carcinoma, Advanced Fibrolamellar Carcinoma
Locations
  • CASI Site 03 San Francisco, California, United States
  • CASI Site 04 Aurora, Colorado, United States
  • CASI Site 02 Boston, Massachusetts, United States
  • Casi Site 01 New York, United States
View Trial Details
Completed

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT02024087

Conditions
Advanced Adult Hepatocellular Carcinoma
Locations
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • University of Kansas Medical Center (KUMC) Westwood, Kansas, United States
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions